Gregory Hunter Babunovic, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 6 | 2023 | 1914 | 0.790 |
Why?
|
| Tuberculosis | 5 | 2023 | 2013 | 0.630 |
Why?
|
| Macrophages | 4 | 2023 | 5771 | 0.210 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 1065 | 0.210 |
Why?
|
| Mycobacterium bovis | 1 | 2023 | 148 | 0.200 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2022 | 100 | 0.200 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 56 | 0.190 |
Why?
|
| Dysentery, Bacillary | 1 | 2021 | 73 | 0.180 |
Why?
|
| Shigella flexneri | 1 | 2021 | 118 | 0.180 |
Why?
|
| Tretinoin | 1 | 2022 | 524 | 0.160 |
Why?
|
| Bacterial Proteins | 2 | 2022 | 3832 | 0.140 |
Why?
|
| Macrophages, Peritoneal | 1 | 2018 | 243 | 0.140 |
Why?
|
| Mycobacterium | 1 | 2018 | 253 | 0.130 |
Why?
|
| Isoniazid | 1 | 2018 | 279 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 890 | 0.120 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2022 | 942 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 1888 | 0.110 |
Why?
|
| Cholesterol | 1 | 2022 | 2898 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1461 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 837 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1959 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 4639 | 0.080 |
Why?
|
| Genomics | 2 | 2022 | 5926 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4404 | 0.060 |
Why?
|
| Antigens, Bacterial | 2 | 2023 | 1145 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2022 | 12122 | 0.050 |
Why?
|
| Terpenes | 1 | 2023 | 102 | 0.050 |
Why?
|
| Nucleosides | 1 | 2023 | 130 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9594 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2023 | 380 | 0.040 |
Why?
|
| Blood Buffy Coat | 1 | 2019 | 10 | 0.040 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2021 | 347 | 0.040 |
Why?
|
| Listeria | 1 | 2018 | 24 | 0.040 |
Why?
|
| Thioglycolates | 1 | 2018 | 37 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2022 | 878 | 0.040 |
Why?
|
| Lysosomes | 1 | 2023 | 932 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2022 | 2655 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23588 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3053 | 0.030 |
Why?
|
| Monocytes | 1 | 2021 | 2592 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2018 | 1140 | 0.020 |
Why?
|
| HIV | 1 | 2019 | 1585 | 0.020 |
Why?
|
| Lipids | 1 | 2023 | 3316 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2036 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3160 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2018 | 5018 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2018 | 3945 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3656 | 0.020 |
Why?
|
| Humans | 6 | 2023 | 765823 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5377 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2592 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 5879 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7425 | 0.020 |
Why?
|
| Vitamin D | 1 | 2019 | 3272 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 15540 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81788 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18970 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9520 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22323 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 10031 | 0.010 |
Why?
|
| Animals | 2 | 2023 | 168730 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 30188 | 0.010 |
Why?
|
| HIV Infections | 1 | 2019 | 17530 | 0.010 |
Why?
|